Skip to main content

Table 1 Characteristics of the trials included in the analysis

From: Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials

Trial

Journal

Cardiac surgery procedure

Number of patients

Statin

Statin regimen

Duration of preoperative therapy

Control

Patients naïve to statin therapy?

Outcomes for meta-analysis

Risk of bias

Almansob 2012 [31]

Arterioscler Thromb Vasc Biol

Non coronary cardiac surgery

132

Simvastatin 20 mg

5–7 days preop and from day 2 postop (no day 0)

5–7 days

No treatment

NR

AF, MI, S, M

High

Baran 2012 [32]

Stem Vell Rev and Rep

CABG

60

Atorvastatin 40 mg

2 weeks preop and postop (no day 0)

2 weeks

Placebo

Yes (>3 months)

AKI, AF, MI, S, M

High

Berkan 2009 [33]

Thorac Cardiov Surg

CABG

46

Fluvastatin 80 mg

3 weeks preop

3 weeks

Placebo

Yes (>1 year)

MI

High

Billings 2016 [21]

JAMA

CABG (49%), valve, or ascending aortic surgery

615

Atorvastatin 40 mg

Bid day 1b, qd day 0, and qd postop

2 days

Placebo

No (Naïve 32%)

AKI, AF, MI, S, M, I

Low

Caorsi 2008 [34]

Eur Cytokine Netw

On-pump CABG

43

Pravastatin 40 mg

2 days preop, 1 hour after CPB, and 7 days postop

2 days

No treatment

NR

AF

High

Carrascal 2016 [51]

J Arrhythm

Valve surgery

90

Atorvastatin 40 mg

7 days preop and 7 days postop

7 days

No treatment

Yes

AKI, AF, MI, S, M

High

Castaño 2015 [35]

J Cardiovasc Surg

On-pump CABG

30

Pravastatin 80 or 40 mg

2 hours before surgery

1 days

Placebo

No (Naïve 0%)

AF, MI, M

Unclear

Chello 2006 [36]

Crit Care Med

On-pump CABG

40

Atorvastatin 20 mg

3 weeks preop

3 weeks

Placebo

Yes (>1 year)

AKI, AF, MI, S, M, I

Unclear

Christenson 1999 [37]

Eur J Cardiothorac Surg

On-pump CABG

77

Simvastatin 20 mg

4 weeks preop

4 weeks

No treatment

NR

AKI, MI, M, I

High

Dehghani 2015 [38]

J Cardiovasc Pharmacol Ther

Valve surgery

58

Atorvastatin 40 mg

3 days preop and 5 days postop

3 days

Placebo

Yes

AF, MI, S, M

Unclear

Ji 2009 [39]

Circ J

Off-pump CABG

140

Atorvastatin 20 mg

7 days preop

7 days

Placebo

Yes

AF, MI, S, M

High

Mannacio 2008 [40]

J Thorac Cardiovasc Surg

On-pump CABG

200

Rosuvastatin 20 mg

7 days preop

7 days

Placebo

Yes (>1 month)

AKI, AF, MI, S, M, I

High

Melina 2009 [41]a

Eur Heart J

On- off-pump CABG

632

Atorvastatin 40 mg

NR

NR

Placebo

NR

AF

High

Park 2016 [42]

Intensive Care Med

Valve surgery

200

Atorvastatin 40 mg

Bid day 1, qd day 0, and qd 3 days postopb

2 days

Placebo

Yes

AKI, AF, MI, S, M

Unclear

Patti 2006 [43]

Circulation

On-pump cardiac surgery (CABG 79%)

200

Atorvastatin 40 mg

7 days preop and postop until discharge (no day 0)

7 days

Placebo

Yes (>1 year)

AF, MI, M

High

Prowle 2012 [44]

Nephrology

On-pump cardiac surgery (CABG 57%)

100

Atorvastatin 40 mg

Days 0 and 3 days postop

1 days

Placebo

No (Naïve 30%)

AKI, M

Low

Song 2008 [45]

Am Heart J

Off-pump CABG

124

Atorvastatin 20 mg

3 days preop, after surgery, and 30 days postop

3 days

No treatment

Yes

AF, MI, S

High

Spadaccio 2010 [46]

J Cardiovasc Pharmacol

On-pump CABG

50

Atorvastatin 20 mg

3 weeks preop

3 weeks

Placebo

Yes (>1 year)

AKI, AF, MI, S, M, I

Unclear

Sun 2011 [47]

Int Heart J

On-pump CABG

100

Atorvastatin 20 mg

7 days preop

7 days

Placebo

Yes (>14 days)

AF, MI

High

Tamayo 2009 [50]

J Thorac Cardiovasc Surg

On-pump CABG

44

Simvastatin 20 mg

3 weeks preop

3 weeks

No treatment

Yes (>3 weeks)

AF, M

High

Vukovic 2011 [48]

Perfusion

On-pump CABG

57

Atorvastatin 20 mg

3 weeks preop

3 weeks

Placebo

Yes (>1 year)

AF, MI, M, I

High

Youn 2011 [49]

Korean J Thorac Cardiovasc Surg

Off-pump CABG

142

Rosuvastatin 20 mg

Bid day 1, qd day 0

2 days

No treatment

No (Naïve 45%)

MI, M

High

Zheng 2016 [22]

N Engl J Med

On-pump CABG (42%), off-pump CABG (43%), AVR, AVR + CABG

1922

Rosuvastatin 20 mg

1–8 days preop and 5 days postop

8 days

Placebo

No (Naïve 66%)

AKI, AF, MI, S, M, I

Low

  1. aAbstract-only publication. bPatients on chronic statin therapy received study drug only on day 0 and day 1, resuming chronic statin therapy on postoperative day 2. CABG coronary artery bypass grafting, AVR aortic valve replacement, CPB cardiopulmonary bypass, preop preoperative regimen, postop postoperative regimen, day 0 the morning of the day of surgery, qd once a day, bid twice a day, AF atrial fibrillation, AKI acute kidney injury, MI myocardial infarction, I infection, M mortality, NR not reported